SCHEMBL29088778

SCHEMBL29088778

NCCCOC(=O)NC(c1ccccc1Cl)C1CCCCC1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.44
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 1/20 0.34
THRB P10828 1/20 0.34
NR1I2 O75469 1/20 0.34
ABCB11 O95342 1/20 0.34
CHRM2 P08172 1/20 0.34
ADRA2A P08913 1/20 0.34
CYP2B6 P20813 1/20 0.34
DRD1 P21728 1/20 0.34
HTR2A P28223 1/20 0.34
SLC6A4 P31645 1/20 0.34
CYP2C19 P33261 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29088816 0.83 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL21158807 0.79 CA1 (0.57) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL29088785 0.69 CA1 (0.44) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL3486328 0.69 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254537 0.69 CA1 (0.51) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254458 0.65 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL3486103 0.65 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL13254459 0.65 MAPT (0.54) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL5373025 0.64 CA1 (0.48) CA1MAPTKDM4EHPGDSMN1; SMN2
SCHEMBL28470733 0.63 GRIN1 (0.53) LMNASLC6A4OPRM1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114805139-B Prodrugs of ketamine, compositions and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2023-10-20 CN disclosed